Suppr超能文献

光化学疗法(PUVA)治疗中根据体表面积计算8-甲氧基补骨脂素剂量

Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment.

作者信息

Sakuntabhai A, Diffey B L, Farr P M

机构信息

Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

出版信息

Br J Dermatol. 1995 Dec;133(6):919-23. doi: 10.1111/j.1365-2133.1995.tb06926.x.

Abstract

In 41 patients about to start PUVA, the dose of 8-methoxypsoralen (8-MOP) was calculated conventionally according to body weight (0.6 mg/kg), or according to body surface area (25 mg/m2) predicted from height and weight measurements. The two different methods of dosing were used on consecutive treatment days and the plasma 8-MOP concentration was measured on each occasion 2 h after ingestion of the crystalline form of 8-MOP, given to the nearest 10 mg. Body weight calculated doses ranged from 30 to 60 mg with a significant difference in the plasma 8-MOP concentration between the dose groups, indicating a systematic variation according to the weight of the patient. When calculated according to body surface area, only two doses were used (40 or 50 mg), and there was no significant difference in plasma 8-MOP concentration between the groups. Calculation of the dose of 8-MOP using body surface area may be performed quickly and simply provided the height and weight of individual patients is known. We provide evidence that this method of dosing will improve the therapeutic effect of PUVA in psoriasis.

摘要

在41例即将开始补骨脂素加长波紫外线(PUVA)治疗的患者中,8-甲氧基补骨脂素(8-MOP)的剂量按照常规方法根据体重(0.6mg/kg)计算,或根据通过身高和体重测量值预测的体表面积(25mg/m²)计算。在连续的治疗日使用两种不同的给药方法,并且在每次摄入最接近10mg的8-MOP结晶形式后2小时测量血浆8-MOP浓度。根据体重计算的剂量范围为30至60mg,各剂量组之间的血浆8-MOP浓度存在显著差异,表明根据患者体重存在系统性变化。根据体表面积计算时,仅使用了两种剂量(40或50mg),且各组之间的血浆8-MOP浓度无显著差异。如果已知个体患者的身高和体重,使用体表面积计算8-MOP剂量可以快速且简单地进行。我们提供的证据表明,这种给药方法将提高PUVA治疗银屑病的疗效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验